Media formats available:
Recommended
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: What has changed significantly in evaluating and considering CV risk in managing patients with diabetes?1
Prof John E Deanfield
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: The evolving role of SGLT2 inhibitors
Prof. Mark Cooper, MD
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: Key challenges in reinforcing CV risk management among diabetic patients
Prof John E Deanfield
- Asian Cardio Diabetes Forum 2019Lecture: Targeting HbA1c in diabetes management: What are the key lessons from glucose lowering trials?
Prof. Nikolaus Marx, MD